- Home
- -
- RESEARCH
- -
- Other Vaccines and Biologicals
- -
- Escherichia coli Vaccine
Escherichia coli Vaccine Project
Vaccine Trial Centre: Escherichia coli Vaccine Project Timeline

2021
2022
2023
Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years (E.mbrace study: VAC52416BAC3001)